Showing results (51-60 of 3,882) with videos related to
Sort By:
Pageof 389
Expert Opinion on Investigational Drugs|April 24, 2019
Pazopanib in patients with advanced intermediate-grade or high-grade liposarcomaFlorence E Chamberlain, Chris Wilding, Robin L Jones, et al.Expert Opinion on Investigational Drugs|July 27, 2016
The potential of SGLT2 inhibitors in phase II clinical development for treating type 2 diabetesK Pafili, E Maltezos, N PapanasExpert Opinion on Investigational Drugs|August 28, 2025
Investigational agents for pancreatic neuroendocrine tumors: what clinical progress have we seen in the last 5 years?Paola Marino, Antonella Argentiero, Davide Quaresmini, et al.Expert Opinion on Investigational Drugs|July 1, 2015
Current drugs in early development for treating hepatitis C virus-related hepatic fibrosisJerzy Jaroszewicz, Marta Flisiak-Jackiewicz, Dariusz Lebensztejn, et al.Expert Opinion on Investigational Drugs|June 18, 2015
Discontinued drug therapies to treat diabetes in 2014Jerry R ColcaExpert Opinion on Investigational Drugs|May 30, 2015
Idalopirdine as a treatment for Alzheimer's diseaseDaniela Galimberti, Elio ScarpiniExpert Opinion on Investigational Drugs|June 13, 2015
An overview of angiogenesis inhibitors in Phase II studies for non-small-cell lung cancerSara Pilotto, Silvia Novello, Umberto Peretti, et al.Expert Opinion on Investigational Drugs|June 16, 2015
Investigational drugs for hyperuricemiaHania Shahid, Jasvinder A SinghExpert Opinion on Investigational Drugs|June 20, 2015
Investigational reverse transcriptase inhibitors for the treatment of HIVTheodore J Cory, Narasimha M Midde, Pss Rao, et al.Expert Opinion on Investigational Drugs|June 23, 2015
Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney diseaseLicette C Y Liu, Elise Schutte, Ron T Gansevoort, et al.Pageof 389